Partners Multiple Sclerosis Center/Brigham and Women's Hospital — Boston, Massachusetts

Partners Multiple Sclerosis Center/Brigham and Women's Hospital is a clinical research site located in Boston, Massachusetts, United States.

Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Partners Multiple Sclerosis Center/Brigham and Women's Hospital has participated in 1 clinical trials.

Therapeutic areas: Multiple Sclerosis, Relapsing-Remitting.

Sponsors: Genzyme, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Partners Multiple Sclerosis Center/Brigham and Women's Hospital?

Partners Multiple Sclerosis Center/Brigham and Women's Hospital has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Partners Multiple Sclerosis Center/Brigham and Women's Hospital conducted?

Partners Multiple Sclerosis Center/Brigham and Women's Hospital has 1 clinical trials on record. Their work covers Multiple Sclerosis, Relapsing-Remitting.

Is Partners Multiple Sclerosis Center/Brigham and Women's Hospital accredited by Crixeo Clinical Trials?

Partners Multiple Sclerosis Center/Brigham and Women's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Partners Multiple Sclerosis Center/Brigham and Women's Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.